Comparative frequency of specified adverse events following Vero cell culture-derived Japanese encephalitis and Vi capsular polysaccharide typhoid vaccines in U.S. military personnel, July 2011–August 2019

Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC; Ixiaro) was approved in the United States in 2009. The previous JE vaccine, an inactivated mouse brain-derived vaccine, had been associated with rare, but serious, allergic and neurologic adverse events (AE). Studies and AE surveil...

Descripción completa

Detalles Bibliográficos
Autores principales: Seshadri, Srihari, Martin, Stacey W., Hills, Susan L., Collins, Limone C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512206/
https://www.ncbi.nlm.nih.gov/pubmed/36725428
http://dx.doi.org/10.1016/j.vaccine.2023.01.061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512206/
https://www.ncbi.nlm.nih.gov/pubmed/36725428
http://dx.doi.org/10.1016/j.vaccine.2023.01.061

Ejemplares similares